[Federal Register Volume 84, Number 21 (Thursday, January 31, 2019)]
[Notices]
[Page 730]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-00274]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Chief Operating
Officer, CDC, pursuant to Public Law 92-463. The grant applications and
the discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention
and Control Special Emphasis Panel (SEP)--Funding Opportunity
Announcement (FOA), PAR 16-098, Cooperative Research Agreements to
the World Trade Center Health Program (U01).
Dates and Times: March 27, 2019, 8:00 a.m.-5:00 p.m., EDT and
March 28, 2019, 8:00 a.m.-12:00 p.m., EDT.
Place: Hampton Inn & Suites Atlanta Buckhead, 3312 Piedmont
Road, Atlanta, Georgia 30305, Telephone: (404) 816-7309.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Nina Turner, Ph.D., Scientific
Review Officer, CDC/NIOSH, 1095 Willowdale Road, Mailstop L10555,
Morgantown, West Virginia 26505, (304) 285-5975, [email protected].
The Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal
Register notices pertaining to announcements of meetings and other
committee management activities, for both the Centers for Disease
Control and Prevention and the Agency for Toxic Substances and
Disease Registry.
Sherri A. Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-00274 Filed 1-30-19; 8:45 am]
BILLING CODE 4163-18-P